v3.26.1
Fair Value Measurements (Tables)
6 Months Ended
Jun. 30, 2026
Fair Value Disclosures [Abstract]  
Schedule of Financial Assets Measured at Fair Value on a Recurring Basis and Indicate the Level of the Fair Value Hierarchy

The following tables present information about the Company’s financial assets measured at fair value on a recurring basis and indicate the level of the fair value hierarchy utilized to determine such fair values (in thousands):

 

 

Fair Value Measurements as of
June 30, 2026:

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

1,075,747

 

 

$

 

 

$

 

 

$

1,075,747

 

U.S. Treasury bills

 

 

 

 

 

9,999

 

 

 

 

 

 

9,999

 

Marketable securities:

 

 

 

 

 

 

 

 

 

 

 

 

U.S. Treasury bills

 

 

 

 

 

33,637

 

 

 

 

 

 

33,637

 

Total assets

 

$

1,075,747

 

 

$

43,636

 

 

$

 

 

$

1,119,383

 

 

 

 

Fair Value Measurements as of
December 31, 2025:

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

27,133

 

 

$

 

 

$

 

 

$

27,133

 

Total assets

 

$

27,133

 

 

$

 

 

$

 

 

$

27,133

 

Schedule of Gross Unrealized Gains and Losses of Marketable Securities

The following table summarizes the gross unrealized gains and losses of the Company’s marketable securities (in thousands):

 

June 30, 2026

 

Amortized Cost

 

 

Unrealized Gains

 

 

Unrealized Losses

 

 

Fair Value

 

Marketable securities:

 

 

 

 

 

 

 

 

 

 

 

U.S. Treasury bills

$

33,655

 

 

$

 

 

$

(18

)

 

$

33,637

 

As of June 30, 2026, all of the Company’s marketable securities had remaining contractual maturities of less than one year.
Schedule of Changes in the Aggregate Fair Value

The following table presents changes in the aggregate fair value of the Company’s Series E preferred stock tranche right liability (in thousands):

 

 

Amount

 

Balance as of December 31, 2024

 

$

2,167

 

Settlement of Series E preferred stock tranche right liability

 

 

(2,167

)

Balance as of June 30, 2025

 

$

 

The following table presents changes in the aggregate fair value of the SAFE (in thousands):

 

 

Amount

 

Balance as of December 31, 2025

 

$

 

Fair value of SAFE at issuance

 

 

50,000

 

Change in fair value of SAFE

 

 

5,556

 

Conversion of SAFE into common stock

 

 

(55,556

)

Balance as of June 30, 2026

 

$